DE68925603D1 - Akridiniumester und Verfahren zum Nachweis von Analyt mit Akridiniumestern und Liposomen - Google Patents

Akridiniumester und Verfahren zum Nachweis von Analyt mit Akridiniumestern und Liposomen

Info

Publication number
DE68925603D1
DE68925603D1 DE68925603T DE68925603T DE68925603D1 DE 68925603 D1 DE68925603 D1 DE 68925603D1 DE 68925603 T DE68925603 T DE 68925603T DE 68925603 T DE68925603 T DE 68925603T DE 68925603 D1 DE68925603 D1 DE 68925603D1
Authority
DE
Germany
Prior art keywords
acridinium esters
analyte
liposomes
detection
acridinium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68925603T
Other languages
English (en)
Other versions
DE68925603T2 (de
Inventor
Say-Jong Law
Uri Piran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Ciba Corning Diagnosys Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Corning Diagnosys Corp filed Critical Ciba Corning Diagnosys Corp
Application granted granted Critical
Publication of DE68925603D1 publication Critical patent/DE68925603D1/de
Publication of DE68925603T2 publication Critical patent/DE68925603T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586Liposomes, microcapsules or cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/64Acridine or hydrogenated acridine ring systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Luminescent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE68925603T 1988-08-01 1989-07-31 Akridiniumester und Verfahren zum Nachweis von Analyt mit Akridiniumestern und Liposomen Expired - Fee Related DE68925603T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22663988A 1988-08-01 1988-08-01

Publications (2)

Publication Number Publication Date
DE68925603D1 true DE68925603D1 (de) 1996-03-21
DE68925603T2 DE68925603T2 (de) 1996-09-26

Family

ID=22849773

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68925603T Expired - Fee Related DE68925603T2 (de) 1988-08-01 1989-07-31 Akridiniumester und Verfahren zum Nachweis von Analyt mit Akridiniumestern und Liposomen

Country Status (6)

Country Link
EP (1) EP0353971B1 (de)
JP (2) JP2601347B2 (de)
AU (2) AU634716B2 (de)
CA (1) CA1339490C (de)
DE (1) DE68925603T2 (de)
HK (1) HK1000098A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656426A (en) * 1988-08-01 1997-08-12 Chiron Diagnostics Corporation Functionaized hydrophilic acridinium esters
CA1339491C (en) * 1988-09-26 1997-10-07 Say-Jong Law Nucleophilic polysubstituted aryl acridinium ester and uses thereof
US5155022A (en) * 1991-02-08 1992-10-13 Becton, Dickinson And Company Assay for lyme disease
US5436155A (en) * 1991-12-31 1995-07-25 Arch Development Corporation Isolated DNA encoding a somatostatin receptor
US5395752A (en) * 1993-03-19 1995-03-07 Ciba Corning Diagnostics Corp. Long emission wavelength chemiluminescent compounds and their use in test assays
US5491072A (en) * 1993-05-17 1996-02-13 Lumigen, Inc. N-alkylacridan carboxyl derivatives useful for chemiluminescent detection
US5731148A (en) * 1995-06-07 1998-03-24 Gen-Probe Incorporated Adduct protection assay
EP0761652A1 (de) * 1995-08-01 1997-03-12 Mochida Pharmaceutical Co., Ltd. Acridiniumverbindung mit mehreren lumineszierenden Gruppen und Bindungsgruppen und Konjugate derselben
WO2000009487A1 (en) * 1998-08-11 2000-02-24 Bayer Corporation Near infrared chemiluminescent acridinium compounds and uses thereof
US6723851B2 (en) * 2001-10-31 2004-04-20 Quest Diagnostics Investment Incorporated Chemiluminescent compounds and use thereof
WO2007062676A1 (en) 2005-12-01 2007-06-07 B.R.A.H.M.S. Aktiengesellschaft Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
EP2074101B1 (de) * 2006-10-13 2012-08-08 Siemens Healthcare Diagnostics Inc. Stabile acridiniumester mit schneller lichtemission
NZ624873A (en) 2011-11-16 2016-07-29 Adrenomed Ag Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
CN104144948B (zh) 2011-11-16 2021-10-15 艾德里诺医药公司 用于治疗的抗肾上腺髓质素(ADM)抗体或抗ADM抗体片段或抗ADM非Ig骨架
SG11201402358RA (en) 2011-11-16 2014-06-27 Adrenomed Ag Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
PT2594587E (pt) 2011-11-16 2014-08-27 Adrenomed Ag Anticorpo anti-adrenomedulina (adm) ou fragmento de anticorpo anti-adm ou andaime proteico não ig anti-adm para diminuir o risco de mortalidade num paciente com uma doença aguda ou crónica ou num estado agudo
PT2780717T (pt) 2011-11-16 2017-02-16 Sphingotec Gmbh Ensaios de adrenomedulina e processos para a determinação de adrenomedulina madura
SG11201402354YA (en) 2011-11-16 2014-06-27 Adrenomed Ag Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
CN103308689B (zh) 2012-03-08 2017-04-12 思芬构技术有限公司 用于预测雌性对象中患上癌症的风险或诊断癌症的方法
CN103308670B (zh) 2012-03-08 2017-06-09 思芬构技术有限公司 用于预测对象患糖尿病和/或代谢综合征的风险的方法
CN103308673B (zh) 2012-03-08 2017-05-31 思芬构技术有限公司 用于预测雌性对象中发生心血管事件的风险的方法
CN110221071A (zh) 2012-10-02 2019-09-10 斯弗因高泰克有限公司 预测女性对象患癌症风险或诊断其癌症的方法
WO2014053501A1 (en) 2012-10-02 2014-04-10 Sphingotec Gmbh A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
ES2710974T3 (es) 2013-01-08 2019-04-29 Sphingotec Gmbh Método para predecir el riesgo de contraer cáncer de mama o diagnosticar cáncer en un sujeto femenino
SG11201505222RA (en) 2013-01-08 2015-08-28 Sphingotec Gmbh Fasting levels of growth hormone as a predictive marker of cardiovascular risk
US20160324881A1 (en) 2013-12-30 2016-11-10 Oncoprevent Gmbh Neurokinin-1 Receptor Antagonists For Use In A Method Of Prevention Of Cancer
US20160097781A1 (en) 2014-10-01 2016-04-07 Sphingotec Gmbh Method for stratifying a female subject for hormone replacement therapy
WO2016066862A2 (en) 2015-02-27 2016-05-06 Sphingotec Gmbh A method for predicting the risk of obesity in a subject
SG11201809252YA (en) 2016-04-21 2018-11-29 Sphingotec Therapeutics Gmbh Methods for determining dpp3 and therapeutic methods
WO2018007588A1 (en) 2016-07-08 2018-01-11 Sphingotec Gmbh Adrenomedullin for assessing congestion in a subject with acute heart failure
EP3309550A1 (de) 2016-10-12 2018-04-18 sphingotec GmbH Verfahren zum nachweis von apolipoprotein e4
EP3339324A1 (de) 2016-12-22 2018-06-27 sphingotec GmbH Anti-adrenomedullin (adm)-antikörper oder anti-adm antikörperfragment oder anti-adm-nicht-ig-gerüst zur verwendung in einer intervention und therapie von verstopfung bei einem darauf angewiesenen patienten
CN110167962B (zh) 2016-12-16 2024-06-07 艾德里诺医药公司 用于干预和治疗需要的患者的充血的抗肾上腺髓质素(ADM)抗体或抗ADM抗体片段或抗ADM非Ig支架
US20200182885A1 (en) 2017-05-30 2020-06-11 Sphingotec Gmbh A method for diagnosing or monitoring kidney function or diagnosing kidney dysfuntion
WO2019081595A2 (en) 2017-10-25 2019-05-02 Sphingotec Therapeutics Gmbh DPP3 BINDER DIRECTED TO AND BINDING SPECIFIC DPP3 EPITOPES AND USE THEREOF IN THE PREVENTION OR TREATMENT OF OXIDATIVE STRESS ASSOCIATED DISEASES / CONDITIONS
MX2020008345A (es) 2018-02-08 2020-09-25 Sphingotec Gmbh Adrenomedulina (adm) para el diagnostico y/o prediccion de demencia y un aglutinante de anti-adrenomedulina para usarse en la terapia o prevencion de demencia.
EP3897686A2 (de) 2018-12-21 2021-10-27 4TEEN4 Pharmaceuticals GmbH Therapieführung und/oder therapieüberwachung für eine behandlung mit angiotensin-rezeptor-agonist und/oder einem vorläufer davon
JP2022544942A (ja) 2019-08-15 2022-10-24 シュピーンゴテック ゲゼルシャフト ミット ベシュレンクテル ハフツング 小児患者における腎機能を診断若しくはモニタリングする、又は腎機能障害を診断する方法
CN114556100A (zh) 2019-08-30 2022-05-27 4Teen4制药有限公司 用于治疗休克的疗法指引和/或疗法监测
EP3871689A1 (de) 2020-02-26 2021-09-01 sphingotec GmbH Anti-adm-antikörper, die an den freien n-terminus binden, für einen beschleunigten übergang von adm-gly zu bio-adm bei patienten mit einem adm-gly/bio-adm-verhältnis über einem schwellenwert und kombination mit vitamin c
EP4111204A1 (de) 2020-02-27 2023-01-04 4TEEN4 Pharmaceuticals GmbH Dpp3 zur therapieführung, überwachung und stratifizierung von nt-adm-antikörpern bei patienten mit schock
IL295728A (en) 2020-02-27 2022-10-01 Adrenomed Ag Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm backbone without ig for use in the treatment of cure or prevention of shock
JP2023516379A (ja) * 2020-03-04 2023-04-19 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド 修飾リポソームを使用する組成物および方法
JP7513734B2 (ja) * 2020-03-04 2024-07-09 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド イムノアッセイシグナルを増幅するための方法
EP3922993A1 (de) 2020-06-12 2021-12-15 4TEEN4 Pharmaceuticals GmbH Dpp3 bei patienten, die mit coronavirus infiziert sind
MX2022011577A (es) 2020-03-16 2022-10-18 Sphingotec Gmbh Proadrenomedulina o fragmento de la misma en pacientes infectados con coronavirus y tratamientos con aglutinante contra la adrenomedulina.
CN115769076A (zh) 2020-03-16 2023-03-07 4Teen4制药有限公司 感染冠状病毒的患者中的dpp3
EP4023218A1 (de) 2020-12-02 2022-07-06 S-Form Pharma Kombinationstherapie für patienten mit akuter und/oder anhaltender dyspnoe
US20240255531A1 (en) 2021-05-07 2024-08-01 Sphingotec Gmbh Mature adrenomedullin for therapy stratification of corticosteroids in critically ill patients
WO2024023368A1 (en) 2022-07-29 2024-02-01 4TEEN4 Pharmaceuticals GmbH Prediction of an increase of dpp3 in a patient with septic shock
WO2024126793A1 (en) 2022-12-15 2024-06-20 4TEEN4 Pharmaceuticals GmbH Dpp3 inhibitor for improvement of pulmonary function in critically ill patients
WO2024200862A1 (en) 2023-03-29 2024-10-03 4TEEN4 Pharmaceuticals GmbH Dpp3 inhibitor for myocardial protection and prevention of myocardial injury in critically ill patients with blood pressure decline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1461877A (en) * 1974-02-12 1977-01-19 Wellcome Found Assay method utilizing chemiluminescence
DE3279029D1 (en) * 1981-12-11 1988-10-20 Welsh Nat School Med Luminescent labelling materials and procedures
DE3645292C2 (de) * 1986-08-22 1997-12-11 Hoechst Ag Chemilumineszenzimmunoassays und ein Verfahren zu ihrer Herstellung
US4745181A (en) * 1986-10-06 1988-05-17 Ciba Corning Diagnostics Corp. Polysubstituted aryl acridinium esters
CA1339491C (en) * 1988-09-26 1997-10-07 Say-Jong Law Nucleophilic polysubstituted aryl acridinium ester and uses thereof

Also Published As

Publication number Publication date
AU634716B2 (en) 1993-03-04
JPH0296567A (ja) 1990-04-09
JP2822320B2 (ja) 1998-11-11
CA1339490C (en) 1997-10-07
EP0353971A3 (en) 1990-10-10
EP0353971B1 (de) 1996-02-07
JPH0925422A (ja) 1997-01-28
EP0353971A2 (de) 1990-02-07
AU3203493A (en) 1993-04-01
DE68925603T2 (de) 1996-09-26
HK1000098A1 (en) 1997-11-21
AU3903389A (en) 1990-02-08
AU654754B2 (en) 1994-11-17
JP2601347B2 (ja) 1997-04-16

Similar Documents

Publication Publication Date Title
DE68925603D1 (de) Akridiniumester und Verfahren zum Nachweis von Analyt mit Akridiniumestern und Liposomen
DE3855715D1 (de) Verfahren und Zusammensetzung zum Nachweis von Chlorid-Ionen in Flüssigkeiten
DE3856407D1 (de) Verfahren und Gerät zur Detektion der Versprödung von Metallen
EP0286994A3 (en) Method and arrangement for the detection of surface flaws
DE3689619D1 (de) Verfahren und vorrichtung zur bestimmung der konzentration von asphalten.
DE68916588D1 (de) Verfahren und Gerät zur Feststellung von Gasen.
DE69329346D1 (de) Vorrichtung und verfahren zur detektion und diskrimination von oberflächenfehlern
DE69332549D1 (de) Vorrichtung und Verfahren zum Zentrifugaltrennen von Vollblut
KR870006621A (ko) 패턴 결함검출방법 및 그 장치
DE3855472D1 (de) Verfahren und Vorrichtung zur Quantifizierung von Nuklearproteinen
DE69325063D1 (de) Verfahren und Vorrichtung zum Nachweis von Mikroorganismen
DE69017923D1 (de) Verfahren und Einrichtung zum Detektieren von nach aussen gerichteten Signalen.
DE3575621D1 (de) Verfahren und anordnung zum kennzeichnen und erkennen von gegenstaenden.
DE3673527D1 (de) Verfahren und vorrichtung zur bestimmung von parametern gasfoermiger substanzen.
DE68918962D1 (de) Verfahren und Vorrichtung zum Durchführen von Analysen mit Mengmöglichkeit.
DE3529792A1 (de) Verfahren und einrichtung zum bestimmen der verformbarkeit von roten blutkoerperchen
DE69420593D1 (de) Verfahren und Vorrichtung zum Erfassen von seismischen Signalen
DE69015286D1 (de) Verfahren und Gerät zum Nachweisen von Fremdkörpern.
DE69408615D1 (de) Verfahren und Vorrichtung zur Erfassung von seismischen Signalen
KR880700266A (ko) 와류를 이용한 결함 검출 방법 및 장치
DE3688985D1 (de) Verfahren und Sonde zum Nachweis von Actinobacillus Actinomycetemcomitans.
DE3684203D1 (de) Verfahren und geraet zum detektieren von gebrochenen filamenten.
DE59310308D1 (de) Verfahren und Mittel zum Nachweis von Listerien
DD243201A5 (de) Verfahren und vorrichtung zur effektiveren einbringung von halmfruechten mit maehdreschern
AT399596B (de) Verfahren und vorrichtung zum bestimmen des orts von in flachglas vorhandenen fehlern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee